Sana Biotechnology Quarterly Cash Flow Statement
NASDAQ: SANAHealthcareBiotechnologyUSD
2.790.00 (0.00%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sana Biotechnology free cash flow
In the quarter ended Jun 30, 2026, Sana Biotechnology generated -$32.8 million of operating cash flow and spent $1.6 million on capital expenditures. That left free cash flow of -$34.4 million.
Summary generated from market data by MetaCap's automated system. Methodology
Sana Biotechnology cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -63.63M | -47.21M | -58.83M | -42.15M | -93.80M | -49.39M | -49.07M | -59.92M | -50.29M | -107.47M | -88.12M | 984.00K |
| Net Income growth (YoY) | — | — | — | — | — | — | — | -6189.84% | — | — | — | — |
| Depreciation & Amortization | 2.20M | 2.39M | 3.10M | 3.20M | 2.90M | 3.65M | 3.80M | 4.10M | 3.90M | 3.75M | 4.21M | 4.50M |
| Stock-Based Compensation | 5.34M | 5.66M | 6.34M | 5.48M | 6.63M | 7.02M | 6.44M | 10.77M | 11.38M | 9.09M | 7.93M | 9.00M |
| Change in Working Capital | -556.00K | 2.08M | -885.00K | 764.00K | 597.00K | -2.86M | 5.55M | 171.00K | -4.41M | -3.44M | 1.25M | 2.41M |
| Operating Cash Flow | -32.79M | -37.38M | -32.64M | -29.43M | -33.10M | -48.66M | -47.16M | -51.82M | -58.54M | -65.63M | -51.96M | -63.55M |
| Capital Expenditures | -1.62M | -288.00K | -873.00K | -41.00K | 112.00K | -136.00K | -436.00K | -4.09M | -13.06M | -15.85M | -14.05M | -2.23M |
| Investing Cash Flow | -87.52M | 49.44M | -16.50M | -48.02M | 7.68M | 16.60M | 47.09M | 41.77M | 5.82M | -77.23M | 15.31M | 51.35M |
| Financing Cash Flow | 93.58M | -128.00K | 17.65M | 109.54M | 561.00K | 982.00K | 643.00K | 2.08M | 10.63M | 186.40M | 1.72M | 187.00K |
| Net Change in Cash | -26.73M | 11.93M | -31.49M | 32.09M | -24.86M | -31.07M | 570.00K | -7.96M | -42.10M | 43.54M | -34.93M | -12.02M |
| Free Cash Flow | -34.41M | -37.67M | -33.51M | -29.47M | -32.99M | -48.79M | -47.60M | -55.91M | -71.60M | -81.48M | -66.00M | -65.78M |
This table shows 12 quarterly periods of Sana Biotechnology's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SANA's reporting calendar. What is a cash flow statement?